Skip to content

A Prospective Multicenter, single-arm Clinical Trial to evaluate the efficacy of a covered stent to treat Portal hypertension complications in the TIPS (Transjugular Intrahepatic Portosystemic Shunt)

A Prospective Multicenter, single-arm Clinical Trial to evaluate a covered stent to treat Portal hypertension complications in the TIPS (Transjugular Intrahepatic Portosystemic Shunt)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077530
Enrollment
Unknown
Registered
2023-11-11
Start date
2023-11-16
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal Hypertension

Interventions

Test group:The covered stent will be used to treat Portal hypertension complications in the TIPS.

Sponsors

Hunan Provincial People 's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age 18 to 80 years old 2) Diagnosed as the complications of portal hypertension 3) Willing to sign the informed consent form

Exclusion criteria

Exclusion criteria: 1) Patients Allergy to nickel titanium alloys 2) Pre-existing TIPS or surgical shunt 3) Isolated gastric variceal bleeding 4) Post-splenectomy 5) INR>1.8 or platelet50% of the portal veins/diffuse intravascular thrombosis in the superior mesenteric vein and splenic vein simultaneously 12) Intrahepatic tract connecting portal and hepatic veins cannot be created. 13) Mental disorders/History of Mental disorders/Inability to cooperate autonomously 14) Lactating, pregnant or planning pregnant women 15) Patients participating in other interventional clinical investigations 16) Not suitable for inclusion in the clinical investigation in the judgment of the investigator

Design outcomes

Primary

MeasureTime frame
Stent Patency Rate at 12 Months;

Secondary

MeasureTime frame
Technical Success Rate;Incidence of MAE within 3 Months;Postoperative Secondary Intervention Rate at 12 Months;Postoperative Incidence of Hepatic Encephalopathy at 12 Months;Incidence of AE;Incidence of SAE;Incidence of Device Defects;Product Performance Evaluation;

Countries

China

Contacts

Public ContactXiang Hua

Hunan Provincial People 's Hospital

vipxiangh@163.com+86 136 6736 7061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026